Green Synthesis of ZnO Nanoparticles from Dysoxylum binectariferum Fruit Extract and Assessment of Antimicrobial Potential
Venu Sharma,Gourav Kumar,Parveen Kumar,Dinesh Kumar,Meena Nemiwal
DOI: https://doi.org/10.1002/slct.202402125
2024-09-10
ChemistrySelect
Abstract:The present investigation focuses on producing ZnO NPs using an efficient, cost‐effective, and eco‐friendly method with aqueous fruit extracts from the Dysoxylum binectariferum plant. Comprehensive characterization of the ZnO NPs was conducted utilizing P‐XRD, FTIR, SEM, EDS, and BET techniques. The anti‐bacterial properties of the synthesized NPs were assessed against Gram‐negative bacteria (E. coli, P. aeruginosa) and Gram‐positive bacteria (S. aureus, S. pyogenes). The results revealed that the synthesized material demonstrated higher efficacy against Gram‐negative bacterial infections, particularly E. coli. Additionally, anti‐fungal activity was evaluated using the C. albicans strain, showing that the ZnO NPs were twice as effective against C. albicans compared to the conventional drug Griseofulvin. In contrast, Griseofulvin, with a minimum inhibitory concentration (MIC) of 500 μM against the C. albicans pathogenic fungal strain, did not exhibit the same level of effectiveness. The current investigation focuses on producing zinc oxide nanoparticles (ZnO NPs) utilizing a quick, economical, and environmentally friendly approach employing aqueous fruit extracts of Dysoxylum binectariferum plant. The ZnO NPs were thoroughly characterized using P‐XRD, FTIR, SEM, EDS, and BET techniques. The synthesized nanoparticles' anti‐bacterial properties were evaluated against Gram‐negative bacteria (E. coli and P. aeruginosa) and Gram‐positive bacteria (S. aureus and S. pyogenes). The findings indicated that the synthesized material exhibited greater efficacy against Gram‐negative bacterial infections, especially E. coli. Furthermore, the anti‐fungal activity was examined using the C. albicans strain, demonstrating that the synthesized ZnO NPs were twice as effective against C. albicans compared to the conventional medication Griseofulvin. In contrast, Griseofulvin, with a 500 μM MIC against the C. albicans pathogenic fungal strain, did not display the same level of efficacy.
chemistry, multidisciplinary